H.U. Group Holdings (MRCH.F) Stock Overview
Operates healthcare business in Japan, the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
MRCH.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
H.U. Group Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥22.95 |
| 52 Week High | JP¥28.06 |
| 52 Week Low | JP¥18.60 |
| Beta | 0.29 |
| 1 Month Change | 9.81% |
| 3 Month Change | n/a |
| 1 Year Change | 2.00% |
| 3 Year Change | 35.00% |
| 5 Year Change | -12.40% |
| Change since IPO | 11.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| MRCH.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 12.6% | -0.2% | 0.6% |
| 1Y | 2.0% | 27.7% | 20.1% |
Return vs Industry: MRCH.F underperformed the US Healthcare industry which returned 27.7% over the past year.
Return vs Market: MRCH.F underperformed the US Market which returned 20.1% over the past year.
Price Volatility
| MRCH.F volatility | |
|---|---|
| MRCH.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MRCH.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MRCH.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 5,157 | Goki Ishikawa | www.hugp.com |
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing (WGS) and proteome analysis; support for clinical trials and research, including pre-trial setup work, specimen collection and transport, measuring, result reports, and data management, as well as SaaS for general practitioners and personal health records. Its In-Vitro Diagnostics segment provides Lumipulse system products, an automated chemiluminescence enzyme immunoassay system that offers reagents; testing services for neurodegenerative diseases; and diagnostics kit for infectious diseases comprising influenza and COVID-19, as well as cerebrospinal fluid reagent.
H.U. Group Holdings, Inc. Fundamentals Summary
| MRCH.F fundamental statistics | |
|---|---|
| Market cap | US$1.26b |
| Earnings (TTM) | US$60.29m |
| Revenue (TTM) | US$1.56b |
Is MRCH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRCH.F income statement (TTM) | |
|---|---|
| Revenue | JP¥248.56b |
| Cost of Revenue | JP¥176.44b |
| Gross Profit | JP¥72.12b |
| Other Expenses | JP¥62.53b |
| Earnings | JP¥9.59b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 174.45 |
| Gross Margin | 29.02% |
| Net Profit Margin | 3.86% |
| Debt/Equity Ratio | 44.8% |
How did MRCH.F perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/17 11:55 |
| End of Day Share Price | 2026/08/12 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
H.U. Group Holdings, Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuko Miyasako | Barclays |
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |
| Tomoko Yoshihara | Daiwa Securities Co. Ltd. |